United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022
United States Insulin Pump Market is likely to reach USD 4 Billion by the year end of 2022.
Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.
The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.
The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.
Key Topics Covered in the Report
Market growth can be attributed to factors such as increasing number of diabetic patients, growing awareness towards diabetes, improved glucose control and flexible, lifestyle-compatible treatment options and technological advancement in insulin pump devices. However, high cost of the insulin pumps is hampering the growth of this market.
The research report titled “United States Insulin Pump Market Insights, Opportunity, Analysis, Growth Potential & Forecast 2017 – 2022” examines the market, competitive landscape and trends of the United States Insulin Pump Market. The report provides an in-depth analysis of the type 1, type 2 and newly diagnosed type 1 diabetes and overall diabetes population. It provides essential insights into insulin pump users with more focused on type 1 and type 2 diabetes insulin pump users. Market outlook in value terms for the forecasted period for Insulin Pump Market has been detailed in the report. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. Additionally, the report includes assessment of clinical trials and preferred insulin pump brand by the patients. Key trends in terms of collaborations, partnerships and licensing agreements are analysed with details. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pump Market.
The report concludes with the profiles of major players in the Insulin Pump Market such as Insulet Corporation, Medtronic, Roche, Animas Corporation and Tandem Diabetes Care. The major market players are evaluated on various parameters such as company overview, product outlook and sales analysis of the Insulin Pump and Diabetes Market from 2011 to 2022.
Key Topics Covered in the Report
- United States Diabetes Population (2011 – 2022)
- United States Insulin Pump Users and Market Analysis (2011 – 2022)
- United States Insulin Pump Preferred Brand – By Product
- United States Insulin Pump Market: Reimbursement & Regulation System
- United States Insulin Pump Market – Major Deal Types
- Insulin Pump Market Clinical Trail Insight by Phase, Company & Country
- Key Companies Analysis
- Key Drivers and Inhibitors of the United States Insulin Pump Market
- Insulet Corporation
- Medtronic
- Roche
- Animas Corporation
- Tandem Diabetes Care
1. EXECUTIVE SUMMARY
2. UNITED STATES DIABETES POPULATION (2011 – 2022): AN ANALYSIS
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
3. UNITED STATES INSULIN PUMP MARKET ANALYSIS (2011– 2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market
4. KEY DRIVERS AND INHIBITORS OF THE UNITED STATES INSULIN PUMP MARKET
4.1 Market Drivers
4.2 Inhibitors
5. UNITED STATES INSULIN PUMP PREFERRED BRAND – BY PRODUCT
5.1 Pediatric
5.2 Adult
6. UNITED STATES INSULIN PUMP MARKET: REIMBURSEMENT & REGULATION SYSTEM
6.1 Reimbursement System
6.2 Regulation System
7. UNITED STATES INSULIN PUMP MARKET – MAJOR DEAL TYPES
7.1 Insulin Pump Market – Collaboration Deals
7.2 Insulin Pump Market – Licensing Agreement
7.3 Insulin Pump Market – Exclusive Agreement
7.4 Insulin Pump Market – Partnerships Deals
8. INSULIN PUMP MARKET CLINICAL TRAIL INSIGHT BY PHASE, COMPANY & COUNTRY
8.1 Year 2016
8.2 Year 2015
8.3 Year 2014
8.4 Year 2013
8.5 Year 2012
9. KEY COMPANIES ANALYSIS
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Insulin Pump – Product Details
9.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.1.4 Insulin Pump – Latest Development & Trends
9.2 Tandem Diabetes Care
9.2.1 Business Overview
9.2.2 Insulin Pump – Product Details
9.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
9.2.4 Insulin Pump – Latest Development & Trends
9.3 Insulet Corporation
9.3.1 Business Overview
9.3.2 Insulin Pump – Product Details
9.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
9.3.4 Insulin Pump – Latest Development & Trends
9.4 Animas Corporation (Johnson & Johnson)
9.4.1 Business Overview
9.4.2 Insulin Pump – Product Details
9.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.4.4 Insulin Pump – Latest Development & Trends
9.5 Roche
9.5.1 Business Overview
9.5.2 Insulin Pump – Product Details
9.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
9.5.4 Insulin Pump – Latest Development & Trends
2. UNITED STATES DIABETES POPULATION (2011 – 2022): AN ANALYSIS
2.1 Overall Diabetes Population
2.1.1 Type 1 Diabetes
2.1.2 Type 2 Diabetes
2.1.3 Newly Diagnosed Type 1 Diabetes
3. UNITED STATES INSULIN PUMP MARKET ANALYSIS (2011– 2022)
3.1 Insulin Pump Users
3.1.1 Type 1 Diabetes Insulin Pump Users
3.1.2 Type 2 Diabetes Insulin Pump Users
3.2 Insulin Pump Market
4. KEY DRIVERS AND INHIBITORS OF THE UNITED STATES INSULIN PUMP MARKET
4.1 Market Drivers
4.2 Inhibitors
5. UNITED STATES INSULIN PUMP PREFERRED BRAND – BY PRODUCT
5.1 Pediatric
5.2 Adult
6. UNITED STATES INSULIN PUMP MARKET: REIMBURSEMENT & REGULATION SYSTEM
6.1 Reimbursement System
6.2 Regulation System
7. UNITED STATES INSULIN PUMP MARKET – MAJOR DEAL TYPES
7.1 Insulin Pump Market – Collaboration Deals
7.2 Insulin Pump Market – Licensing Agreement
7.3 Insulin Pump Market – Exclusive Agreement
7.4 Insulin Pump Market – Partnerships Deals
8. INSULIN PUMP MARKET CLINICAL TRAIL INSIGHT BY PHASE, COMPANY & COUNTRY
8.1 Year 2016
8.2 Year 2015
8.3 Year 2014
8.4 Year 2013
8.5 Year 2012
9. KEY COMPANIES ANALYSIS
9.1 Medtronic
9.1.1 Business Overview
9.1.2 Insulin Pump – Product Details
9.1.3 Medtronic – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.1.4 Insulin Pump – Latest Development & Trends
9.2 Tandem Diabetes Care
9.2.1 Business Overview
9.2.2 Insulin Pump – Product Details
9.2.3 Tandem Diabetes Care – Insulin Pump Sales Analysis & Forecast (2013 – 2022)
9.2.4 Insulin Pump – Latest Development & Trends
9.3 Insulet Corporation
9.3.1 Business Overview
9.3.2 Insulin Pump – Product Details
9.3.3 Insulet Corporation – Insulin Pump Sales Analysis & Forecast (2011 – 2022)
9.3.4 Insulin Pump – Latest Development & Trends
9.4 Animas Corporation (Johnson & Johnson)
9.4.1 Business Overview
9.4.2 Insulin Pump – Product Details
9.4.3 Johnson & Johnson – United States Diabetes Sales Analysis & Forecast (2013 – 2022)
9.4.4 Insulin Pump – Latest Development & Trends
9.5 Roche
9.5.1 Business Overview
9.5.2 Insulin Pump – Product Details
9.5.3 Roche – North America Diabetes Sales Analysis & Forecast (2011 – 2022)
9.5.4 Insulin Pump – Latest Development & Trends
LIST OF TABLES
Table 7–1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 7–2: Licensing Agreement in Insulin Pump Market, 2009 – 2016
Table 7–3: Exclusive Agreement in Insulin Pump Market, 2011 – 2016
Table 7–4: Partnerships Deals in Insulin Pump Market, 2010 – 2016
Table 7–1: Collaboration Deals in Insulin Pump Market, 2009 – 2016
Table 7–2: Licensing Agreement in Insulin Pump Market, 2009 – 2016
Table 7–3: Exclusive Agreement in Insulin Pump Market, 2011 – 2016
Table 7–4: Partnerships Deals in Insulin Pump Market, 2010 – 2016
LIST OF FIGURES
Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3–1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 3–2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3–3: United States – Type 1 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–4: United States – Forecast for Type 1 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–5: United States – Type 2 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–6: United States – Forecast for Type 2 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–7: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3–8: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 9–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 9–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 9–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9–7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9–8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9–9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 9–10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 2–1: United States – Overall Diabetes Population (Thousand), 2011 – 2016
Figure 2–2: United States – Forecast for Overall Diabetes Population (Thousand), 2017 – 2022
Figure 2–3: United States – Type 1 Diabetes Population (Thousand), 2011 – 2016
Figure 2–4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2022
Figure 2–5: United States – Type 2 Diabetes Population (Thousand), 2011 – 2016
Figure 2–6: United States – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2022
Figure 2–7: United States – Newly Diagnosed Type 1 Diabetes Population (Number), 2011 – 2016
Figure 2–8: United States – Forecast for Newly Diagnosed Type 1 Diabetes Population (Number), 2017 – 2022
Figure 3–1: United States – Insulin Pump Users (Number), 2011 – 2016
Figure 3–2: United States – Forecast for Insulin Pump Users (Number), 2017 – 2022
Figure 3–3: United States – Type 1 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–4: United States – Forecast for Type 1 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–5: United States – Type 2 Diabetes Insulin Pump Users (Number), 2011 – 2016
Figure 3–6: United States – Forecast for Type 2 Diabetes Insulin Pump Users (Number), 2017 – 2022
Figure 3–7: United States – Insulin Pump Market (Million US$), 2011 – 2016
Figure 3–8: United States – Forecast for Insulin Pump Market (Million US$), 2017 – 2022
Figure 9–1: Medtronic – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9–2: Medtronic – Forecast for United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9–3: Tandem Diabetes Care – Insulin Pump Sales Analysis (Million US$),2013 – 2016
Figure 9–4: Tandem Diabetes Care – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9–5: Insulet Corporation – Insulin Pump Sales Analysis (Million US$),2011 – 2016
Figure 9–6: Insulet Corporation – Forecast for Insulin Pump Sales Analysis (Million US$),2017 – 2022
Figure 9–7: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2013 – 2016
Figure 9–8: Johnson & Johnson – United States Diabetes Sales Analysis (Million US$),2017 – 2022
Figure 9–9: Roche – North America Diabetes Sales Analysis (Million US$),2011 – 2016
Figure 9–10: Roche – Forecast for North America Diabetes Sales Analysis (Million US$),2017 – 2022
